Dishman Carbogen Amcis (DCAL) Stock Overview

Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.

DCAL Stock Information

Symbol

DCAL

Address

Dishman Corporate HouseAhmedabad, 380058India

Founded

Trading hours

Website

https://imdcal.com

Country

🇮🇳 India

Phone Number

91 27 1742 0102

Dishman Carbogen Amcis (DCAL) Price Chart

Dishman Carbogen Amcis Overview: Key Details and Summary

Stock data	2023	Change
Price	$2.38	N/A
Market Cap	$372.81M	N/A
Shares Outstanding	156.78M	0.00%
Employees	1.29K	N/A
Shareholder Equity	58.10B	4.70%

Valuation	2023	Change
P/E Ratio	-1.25	N/A
P/S Ratio	1.30	N/A
P/B Ratio	0.01	N/A

Growth	2023	Change
Return on Equity	-0.0001	N/A

Earnings	2023	Change
Revenue	$287.65M	N/A
Earnings	-$3.55M	N/A
EPS	-1.90	N/A
Earnings Yield	-0.799	N/A
Gross Margin	0.7808	N/A
Operating Margin	0.0437	N/A
Net income margin	-0.0124	N/A

Financial Strength	2023	Change
Total Assets	$1.13B	N/A
Total Debt	$263.33M	N/A
Cash on Hand	$42.70M	N/A
Debt to Equity	0.0075	12.69%
Cash to Debt	0.1622	-34.68%
Current Ratio	$1.07	-17.63%